IDEAYA Biosciences, Inc. 8-K

What Happened On May 5, 2026, IDEAYA Biosciences, Inc. announced its financial results for the quarter ended March 31, 2026 and furnished the full press release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02). The filing provides the company’s quarterly results and related commentary in the press release; the Form 8-K also includes the Inline XBRL cover page (Exhibit 104).

Key Details

• Announcement date: May 5, 2026; reporting period: quarter ended March 31, 2026.
• Filing: Current Report on Form 8-K, Item 2.02 (Results of Operations and Financial Condition).
• Press release included as Exhibit 99.1 to the 8-K.
• Inline XBRL cover page provided as Exhibit 104.

Why It Matters Quarterly results can affect analyst expectations, share price, and investor views of the company’s clinical and financial progress. Retail investors should read the company’s press release and related financials in the 8-K to see revenue, operating expenses, net income/loss, cash position, and any management commentary or guidance disclosed. The 8-K indicates IDEAYA chose to make these results public promptly via a press release rather than only in a periodic filing.